Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Tranexamic Acid (500mg)
Therapeutic Category
Gynecology and Fertility
Dosage Form
Tablet
Packaging Type
Alu ALu
Packaging
10*10
Price
₹207/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Traxlink 500 is a pharmaceutical formulation containing tranexamic acid, a synthetic derivative of the amino acid lysine. This medication is designed to reduce excessive bleeding by inhibiting the breakdown of fibrin, a protein essential for blood clotting. By stabilizing the blood clot and preventing its dissolution, Traxlink 500 is an effective treatment for various conditions associated with abnormal bleeding.
Clinically, Traxlink 500 is indicated for managing heavy menstrual bleeding (menorrhagia), surgical bleeding, trauma-related hemorrhage, and certain bleeding disorders. It may also be used in dental procedures for patients with coagulopathies or those on anticoagulant therapy, helping to minimize blood loss and enhance patient safety during and after surgery.
Common side effects may include gastrointestinal disturbances, headache, dizziness, and fatigue. Serious side effects are rare but can include thromboembolic events and allergic reactions.
Traxlink 500 is indicated for the treatment of heavy menstrual bleeding, surgical bleeding, and trauma-related hemorrhage.
Consult a healthcare professional before use, especially if pregnant, breastfeeding, or taking other medications, to avoid potential interactions and ensure safe usage. In summary, Traxlink 500 is a crucial option for patients experiencing excessive bleeding, providing an effective solution to enhance clotting and minimize risks associated with blood loss. Always follow the guidance of a healthcare provider to optimize treatment outcomes and ensure safety.
Store in a cool, dry place, away from direct sunlight, and out of reach of children.
Composition : Ceftriaxone (250mg) + Sulbactam (125mg)
Composition : Ceftriaxone (250mg) + Tazobactum (31.25mg)
Composition : Ceftriaxone (500mg)
Composition : Ceftriaxone (500mg) + Sulbactam (250mg)
Composition : Cefuroxime (1500mg)
Composition : Cefuroxime (1.5gm)
Composition : Cefuroxime (1500mg) + Sulbactam (750mg)
Composition : Clarithromycin (500mg) Injection
Composition : Clindamycin (300mg) Injection
Composition : Clindamycin (600mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Tranexamic Acid 500mg Tablet has strong demand in the gynecology, surgery, hematology, and general medicine segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on hemostatic and women's healthcare portfolios.
Medical distributors and agencies can benefit from consistent demand for bleeding disorder management under medical supervision. Tranexamic Acid 500mg is an antifibrinolytic agent that helps prevent excessive bleeding by stabilizing blood clots Commonly prescribed for heavy menstrual bleeding (menorrhagia), post-operative bleeding, dental procedure-related bleeding, nosebleeds, and other bleeding conditions Helps reduce blood loss and supports effective clot stabilization Widely used by gynecologists, surgeons, dentists, and general physicians Frequently prescribed in both hospital and outpatient settings This strengthens a comprehensive gynecology and hemostatic care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Tranexamic Acid 500mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong demand across gynecology and surgical specialties, repeat prescriptions, institutional procurement opportunities, reliable supply chain support, and attractive margins in the hemostatic segment.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from comprehensive marketing support, quality pharmaceutical products, and a dependable supply chain to grow their business successfully.